18. Referências

ALENCAR, Y.M. et al. Fatores de risco para aterosclerose em uma populaçcão idosa ambulatorial na cidade de são paulo. Arquivos Brasileiros de Cardiologia. v. 74, n. 3, p. 181-188, 2000.

BARTER, P. Role of lipoproteins in inflammation. Publicação eletrônica. Disponível em http://www.lipidsonline.org/slides/ slide01.cfm?q=tnf&dpg=5. Acesso: 20 fev. 2002.

BERRY, C. et al Oxidative stress e vascular damage in hypertension. Current opinion in Nephrology and Hypertension v. 10, p. 247-255, 2001.

BLACK, P. H. & GARBUTT, L. D. Stress, inflammation and cardiovascular disease Journal of Psychosomatic Research v. 52, p. 1-23, 2002.

COSTA, R.P. & MARTINEZ, T. L. R. Terapia nutricional na hipercolesterolemia. Revista da Sociedade de Cardiologia de Estado de São Paulo. v.7, n. 4, p. 475-484, Jul/Ago 1997.

COUTINHO, M.S.S.A.; NAKAMAE, F.J.D.; MENEZES, M. E. Chlamydia pneumoniae and atherosclerosis. Identification of bacterial dna in the arterial wall. Arquivos Brasileiros de Cardiologia. v.74, n. 2, p. 124-128, 2000.

CYBULSKY, M.I. & GIMBRONE, M.A. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science v. 251, p.788-791, 1991.

DANDONA, P. & ALJADA, A. A rational approach to pathogenesis and treatment of type 2 Diabetes Mellitus, insulin resistance, inflammation, and atherosclerosis. The American Journal of Cardiology v. 90 (Suppl), p. 27gi-33gi, 2002.

DAWBER T.R., KANNEL W.B. The Framingham Study. An epidemiological approach to coronary heart disease. Circulation v. 34, n. 4, p. 553-555, 1966.

FRANÇOSO, L.M. & COATES, V. Evidências anatomopatológicas do início da aterosclerose na infância e adolescência. Arquivos Brasileiros de Cardiologia. v.78, n. 1, p. 131-136, 2002.

FROHLICH, J. et al. The role of risk factors in the development of atherosclerosis. Critical Reviews in Clinical Laboratory Sciences v. 38, n. 5, p.401-440, 2001.

GINSBERG, H.N. & GOLDBERG, I.J. Distúrbios do Metabolismo das Lipoproteínas. In: FAUCI et al Harrison Medicina Interna Vol II. 14. Ed. Rio de Janeiro: Editora McGraw-Hill Interamericana do Brasil Ltda., p. 2270-2281, 1998.

GUS, I.; FFISCHMANN,A.; MEDINA,C. Prevalência dos fatores de risco da doença arterial coronariana no estado do Rio Grande do Sul. Arquivos Brasileiros de Cardiologia v.78, n. 5, p. 478-483, 2002.

KALAYOGLU, M. V.; LIBBY, P.; BYRNE, G. I. Chlamydia pneumoniae as a Emerging risk factor in cardiovascular disease. Journal of the American Medical Association v. 288, p. 2724-2731, 2002.

KWITEROVICH, P. O. The Metabolic Pathways of High-Density Lipoprotein, Low-Density Lipoprotein, and Triglycerides: A Current Review. The American Journal of Cardiology. v. 86 (Suppl), p. 5L-10L, 2000.

LIBBY, P. Inflammation in atherosclerosis Nature v. 420, p.868-874, dec. 2002.

LIBBY, P. Managing the risk of atherosclerosis: the role of high-density lipoprotein. The American Journal of Cardiology v. 88 (Suppl), p. 3N-8N, 2001a.

LIBBY, P. Current concepts of the pathogenesis of the acute coronary syndromes Circulation v. 104, p. 365-372, 2001b.

LIBBY, P.; RIDKER, P. M.; MASERI, A. Inflammation and Atherosclerosis Circulation v. 105, p.1135-1143, 2002.

LUSIS, A. J. Atherosclerosis Nature v. 407, p. 233-241, 2000.

MANGONI, A. A. & JACKSON, S. H. D. Homocysteine and Cardiovascular Disease: Current Evidence and Future Prospects. American Journal of Medicine v.112, p. 556-565, 2002.

NGEH, J.; ANAND, V.; GUPTA, S. Chlamydia pneumoniae and atherosclerosis – what we know and what we don’t Clinical microbiology and infection v. 8, p.2-13, 2002.

NIELSEN, L. B. Atherogenecity of lipoprotein (a) and oxidized low density lipoprotein: insinght from in vivo studies of arterial wall influx, degradation and efflux. Atherosclerosis. v.143, p. 229-243, 1999.

NOFER, J-R. et al. HDL and arteriosclerosis: beyond reverse cholesterol transport Atherosclerosis v. 161, p. 1-16, 2002.

OLIVEIRA, J.J. & SILVA, S.R.A.S. Fatores de risco para doença arterial coranariana. ARS CVRANDI – A Revista da Clínica Médica, p. 29-40, Jun. 1999.

RADER, D. J. High-density lipoproteins and atherosclerosis The American Journal of Cardiology v. 90 (Suppl), p. 62i-70i, 2002.

RIDKER, P. M. High-Sensitivity C-Reactive Protein: Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation v. 103, p.1813-1818, 2001.

ROSS, R. Mechanisms of disease: atherosclerosis – an inflammatory disease. The New England Journal of Medicine, v. 340, n. 2, p. 115-126, 14 January 1999.

SALES, R. P. & PERCÁRIO, S. Devemos avaliar o estresse oxidativo e a defesa antioxidante de nossos pacientes? Laes & Haes p.122-142, abril/maio 2001.

SCHACHTER, M. The pathogenesis of atherosclerosis International Journal of Cardiology. v. 62 (Suppl. 2), p. s3-s7, 1997.

SCHIFFRIN, E. L. Beyond Blood Pressure: The Endothelium and Atherosclerosis Progression Clinical studies in which treatment with angiotensin converting American Journal of Hypertension, v. 15, p. 115S–122S, 2002.

SCHOEN, F.J. & COTRAN, R.S. Vasos Sanguíneos. In: COTRAN et al Robins Patologia Estrutural e Funcional. 6. Ed. Rio de Janeiro: Editora Guanabara Koogan, 2000. p. 446, 454.

SOUZA, M. F. M et al Tendências do risco de morte por doenças circulatórias nas cinco regiões do Brasil no período de 1975 a 1996. Arquivos Brasileiros de Cardiologia, v.77, n. 6, p. 562-568, 2001.

STARY, H.C. et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation v. 92, n. 5, p. 1355-1374, 1 Set 1995.

STEIN, O. & STEIN, Y. Atheroprotective mechanisms of HDL Atherosclerosis v. 144, p. 285-301, 1999.

TALL, A. R.; COSTET, P.; WANG, N. Regulation and mechanisms of macrophage cholesterol efflux. The Journal of Clinical Investigation v.110, p. 899-904, 2002.

TEGOS, T. J. et al The genesis of atherosclerosis and risk factors: a review . Angiology v.52, n. 2, p. 89-97, 2001.